%0 Journal Article
%T Multiple sclerosis and pregnancy: Pathogenesis, influencing factors, and treatment options.
%A Wang Y
%A Wang J
%A Feng J
%J Autoimmun Rev
%V 22
%N 11
%D 2023 Nov 21
%M 37741528
%F 17.39
%R 10.1016/j.autrev.2023.103449
%X Multiple sclerosis (MS) is an autoimmune-mediated degenerative disease of the central nervous system, characterized by inflammatory demyelination. It is primarily found in women of childbearing age, making pregnancy a significant concern for both patients with MS and clinicians. To assist these patients in achieving their desire for pregnancy, reducing MS relapses during all stages of pregnancy, preventing the progression of MS, mitigating the impact of MS treatment on the course and outcome of pregnancy, and a thorough understanding of the relationship between pregnancy and MS, as well as specific management and the application of relevant medications for MS patients at each stage of pregnancy, are essential. This article provides an update on pregnancy-related issues in women with MS, including the general recommendations for management at each stage of pregnancy.